Download Your Complimentary Copy of the Agenda

The 7th Genome Editing Therapeutics Summit is your unique forum to learn, network and partner with the brightest minds advancing genome editing therapies from the lab to patients.

7th Genome Editing Therapeutics Summit 2026 Brochure Cover Image

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

Attending Companies Include

AbbVie - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Arbor Biotechnologies - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Bristol Myers Squibb - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Cytodigm - Attending Company - 7th Genome Editing Therapeutics Summit 2026
egenesis - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Eli Lilly & Co. - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Emendo Bio - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Epicrispr Biotechnologies - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Full Circle Therapeutics - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Intellia Therapeutics - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Komo Biosciences - Attending Company - 7th Genome Editing Therapeutics Summit 2026
Metagenomi Therapeutics - Attending Company - 7th Genome Editing Therapeutics Summit 2026
- Attending Company - 7th Genome Editing Therapeutics Summit 2026

80%

Director, VP & C-Suite Speaker Faculty

50:50

Clinical & Preclinical Speakers

64% / 36%

In Vivo / Ex Vivo Agenda

5+

Hours of Meaningful Networking

2

Brand-New Workshops